Prolotherapy and joint hypermobility

Dr. Fred G. Arnold

· December/January 2013

Prolotherapy and joint hypermobility

Hypermobile joints are sometimes referred to as loose joints, those who have them are labeled “double jointed.” Hypermobility of a joint can be entertaining when we see nimble performers Cirque Du Soleil contort their bodies in strange awkward ways. However, for some individuals, hypermobility is a very painful serious condition.

Joint hypermobility — Joint hypermobility occurs in approximately 10 to 20 percent of the population in Western countries has a higher rate in Indian, Chinese Middle Eastern populations. These are people who are hypermobile without pain symptoms.

Those people with painful symptoms attributable to their hypermobility may have joint hypermobility syndrome (JHS) Ehlers-Danlos Syndrome (EDS), which are genetic disorders of connective tissue characterized by joint laxity hypermobility. Both conditions affect collagen synthesis involving the joints almost every bodily system.

Collagen is the tissue that helps to form strong tendons, ligaments, muscles, bones, cartilage, menisci, blood vessels even the skin. Many JHS patients present with signs symptoms suggestive of fibromyalgia thus, they are frequently misdiagnosed. The Brighton criteria, which involves objective measurement of the hyperextensibility of various joints, is effectively used as a diagnostic tool.

Joint pain is the major presenting complaint of JHS EDS, if the hypermobility is not treated, joint dislocations, degeneration of the joint degenerative joint disease can occur. Other conditions associated with hypermobile joints include rotator cuff injuries, recurrent sprains strains, scoliosis, neck back injuries due to soft tissue injury, disc herniation, TMJ syndrome flat feet.

Many hypermobile patients also experience muscle pain, which may be explained by the extra stress placed on muscles as they compensate for lax joints in an attempt to stabilize them. The traditional treatments for joint hypermobility include education/lifestyle advice, behavior modification, physical therapy, taping bracing, pain medication. While these treatments may offer a reduction in pain symptoms, they do not address the cause of the problem do little to curb the progressive debilitation of the disease.

If joint mobility becomes severe enough, some individuals seek surgical intervention. Studies have shown suboptimal results in the hypermobile patients, compared to the normal population. In general, traditional medical treatments are limited to temporary symptom relief.

Prolotherapy joint hypermobility — Prolotherapy has great success in treating joint injuries, including joint hypermobility. It is designed to treat strengthen joint laxity that accompanies JHS EDS. Prolotherapy causes a brief, localized inflammatory response to the weakened joint stimulates the formation of new collagen, which improves strength the ability to handle strain force on the joint. High-resolution ultrasounds MRIs have confirmed that prolotherapy does stimulate tissue growth.

Summary — The best approach for weakened, hypermobile joints is to directly address the root of the disability, stimulate the repair of the connective tissues, such as ligaments joint capsules, stabilize the affected joints.

Prolotherapy should always be considered when other treatments have been unsuccessful especially when surgery has been recommended. It can provide relief, help slow down the degenerative changes associated with hypermobile joints, prevent joint surgeries treat painful hypermobile joints without the negative effects of pain medications.

Reference — Journal of Prolotherapy. 2011;3(2):612-629.

Fred G. Arnold, D.C., N.M.D., specializes in prolotherapy/pain rehabilitation services. He is a Diplomate of the American Academy Health Care Providers one of the few physicians in the nation with both naturopathic chiropractic degrees. , or.

Reprinted from AzNetNews, Volume 31, Number 6, December 2012/January 2013.

Found this helpful? Share it with someone who needs it.